Long-term data on patients taking GLP-1 RAs for weight loss are limited
You may change your injection day if at least 3 days have passed since your last dose
Observational studies in patients with prior pancreatic disease have shown that carefully selected individuals tolerate GLP-1 therapy without recurrence, provided baseline pancreatic function is assessed and monitoring continues throughout treatment
This innovative method helps curb cravings, promotes sustainable weight loss, and enables you to lead a healthier life
Gao C, Jiang J, Tan Y, Chen S
Tirzepatide works by activating both GLP-1 and GIP receptors in your brain and pancreas, creating a dual hormone-mimicking effect that reduces hunger signals and increases feelings of fullness